HMGB1 and polycystic ovary syndrome: In this study, we identified SNHG12, a lncRNA downregulated in GCs of PCOS patients, as a molecule that competitively disrupts the interaction between HMGB1 and the PTEN promoter, thereby regulating the glycolytic pathway in GCs.